entrezID,gene_symbol,biotype,bioproject,res_design,host_type,stimulator,concentration,H.P.S,baseMean,log2FoldChange,lfcSE,stat,pvalue,padj,cell_type
101927021,ZFAND2A-DT,lncRNA,PRJNA474093,IFN-beta stimulation vs. mock stimulation,immortalized human hepatocytes PH5CH8,IFN-beta,N.A.,12,158.604811518206,-0.0747199755083791,0.164777549504552,-0.453459683877112,0.650217767783779,0.961473650102656,NA
101927021,ZFAND2A-DT,lncRNA,PRJNA565586,IFN-gamma stimulation vs. mock stimulation,NA,IFN-gamma,100U/ml,24,194.776677960287,0.0179374268114171,0.136434603129721,0.131472708535403,0.895401374589942,0.989576251310632,patient-derived GBM cell lines (PDGCLs)
101927021,ZFAND2A-DT,lncRNA,PRJNA667475,IFN-beta stimulation vs. mock stimulation,NA,IFN-beta,250U/ml,8,256.277802233352,-0.432504708790522,0.132999399309804,-3.25192979092381,0.00114624331949044,0.00784852525619806,A549
101927021,ZFAND2A-DT,lncRNA,PRJNA739760,INF-alpha2 stimulation (with DMSO) vs. mock stimulation (with DMSO),NA,IFN-alpha,1000U/ml,16,122.199449710234,-0.0767481133752699,0.189108827964273,-0.405840986914527,0.684859440874114,0.986418245486816,A549
101927021,ZFAND2A-DT,lncRNA,PRJNA768480,IFN-gamma stimulation vs. mock stimulation,NA,IFN-gamma,N.A.,N.A.,209.532955004746,-0.302035145404579,0.221534192235747,-1.36337936079486,0.17276298229342,0.388062029774053,A549
101927021,ZFAND2A-DT,lncRNA,PRJNA788896,IFN-beta stimulation vs. mock stimulation,NA,IFN-beta,N.A.,N.A.,122.292881898244,-0.24662807381419,0.171421809320208,-1.43872051515628,0.150229724414989,1,sigmoid colon organoid
101927021,ZFAND2A-DT,lncRNA,PRJNA788896,IFN-beta stimulation vs. mock stimulation,NA,IFN-beta,N.A.,N.A.,122.292881898244,-0.0662342561136735,0.168684232394692,-0.392652325433102,0.694576286975216,1,sigmoid colon organoid
